- Movano Health (MOVE, Financial) received a Nasdaq deficiency notice for missing the Q1 2025 Form 10-Q filing deadline.
- The company must submit a compliance plan by July 21, 2025.
- If the plan is accepted, Movano Health could get an extension until November 11, 2025, to file the delayed report.
Movano Health (MOVE), a company known for its innovative healthcare solutions, has received a notification from Nasdaq due to non-compliance with listing rules. The deficiency stems from the company's failure to file its Form 10-Q for Q1 2025 by the May 15, 2025, deadline, as required by Nasdaq Listing Rule 5250(c)(1).
Nasdaq has given Movano Health until July 21, 2025, to submit a plan to regain compliance. Should Nasdaq accept this compliance plan, the company stands to gain an extension of up to 180 calendar days, which would allow them until November 11, 2025, to file the missing Form 10-Q and achieve compliance. However, if Nasdaq does not accept the proposed plan, Movano Health will have the opportunity to appeal this decision to a Nasdaq Hearings Panel.
This situation poses a risk of potential delisting from Nasdaq for Movano Health if they fail to submit an acceptable compliance plan by the stipulated deadline or to file the delayed report within any extended timeframe granted. This notice comes in the wake of other company activities, as Movano Health continues to develop its suite of healthcare technologies and wearable medical devices. The company's market cap currently stands at $7.27 million, positioning it within the medical devices sector.
